Pub Date : 2019-08-14DOI: 10.37591/rrjomv.v9i2.738
A. Srivastava, N. Kachhwaha
Zika virus is an arbovirus (arthropod-borne virus) which belongs to the family Flaviviridae that was first isolated in 1947 from blood of a febrile rhesus macaque monkey during a yellow fever study in the Zika forest of Uganda and later identified in Aedes africanus mosquito from the same forest. But in 2007, the first major outbreak of Zika virus infection occurred in Yap Island (Federated States of Micronesia), where, it was noticed that an outbreak of illness characterized by rashes, conjunctivitis, subjective fever, arthralgia, and arthritis. Approximately 73% of the population were infected and out of which 18% developed symptomatic disease. In 2015, an estimated 1.5 million cases were reported in Brazil. In 2017, 305 cases were reported from US kingdom and in 2018, 109 cases from India (Rajasthan, Gujrat and Madhya Pradesh). The best method to diagnose the disease is by RT-PCR and till date there is no vaccine or specific treatment available. The most acceptable method for prevention is to reduce egg laying sites of the adult mosquito. Continued researches of vaccine development, treatment, medication and prevention strategies are in progress to eradicate the disease.
{"title":"A Review- Recent Outbreak of Zika Viruses in India, its Vectorology and Virology","authors":"A. Srivastava, N. Kachhwaha","doi":"10.37591/rrjomv.v9i2.738","DOIUrl":"https://doi.org/10.37591/rrjomv.v9i2.738","url":null,"abstract":"Zika virus is an arbovirus (arthropod-borne virus) which belongs to the family Flaviviridae that was first isolated in 1947 from blood of a febrile rhesus macaque monkey during a yellow fever study in the Zika forest of Uganda and later identified in Aedes africanus mosquito from the same forest. But in 2007, the first major outbreak of Zika virus infection occurred in Yap Island (Federated States of Micronesia), where, it was noticed that an outbreak of illness characterized by rashes, conjunctivitis, subjective fever, arthralgia, and arthritis. Approximately 73% of the population were infected and out of which 18% developed symptomatic disease. In 2015, an estimated 1.5 million cases were reported in Brazil. In 2017, 305 cases were reported from US kingdom and in 2018, 109 cases from India (Rajasthan, Gujrat and Madhya Pradesh). The best method to diagnose the disease is by RT-PCR and till date there is no vaccine or specific treatment available. The most acceptable method for prevention is to reduce egg laying sites of the adult mosquito. Continued researches of vaccine development, treatment, medication and prevention strategies are in progress to eradicate the disease.","PeriodicalId":230442,"journal":{"name":"Research & Reviews: A Journal of Microbiology and Virology","volume":"188 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132296354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.37591/rrjomv.v11i3.2585
S. Selvaraj, Chellasamy Prashanth, Gurusamy Ponraj, K. Rameshkumar
{"title":"Antibacterial Activities of Medicinal Plant Leaves Extract Against Isolated Escherichia coli Bacteria from Different Water Sources","authors":"S. Selvaraj, Chellasamy Prashanth, Gurusamy Ponraj, K. Rameshkumar","doi":"10.37591/rrjomv.v11i3.2585","DOIUrl":"https://doi.org/10.37591/rrjomv.v11i3.2585","url":null,"abstract":"","PeriodicalId":230442,"journal":{"name":"Research & Reviews: A Journal of Microbiology and Virology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115511283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.37591/rrjomv.v11i3.2748
Ilyes Zatla, L. Boublenza, H. Hassaine
Several vaccines are found for the novel coronavirus SARS-CoV-2, responsible for the Coronavirus Disease 'COVID-19' but with a no clear, unified and effective treatment plan, nor definitive therapies for it, but only a variety of potential approaches. The objective of this work was to present, an overview of a variety of therapeutic and preventive approaches that have been applied instead, in a matter to calm the fatal viral pneumonia and developing safe, effective, anti-coronavirus therapeutic agents from naturally derived compounds would make a hopeful solution to end this pandemic. A number of experimental therapies have been rushed into clinical trials for COVID-19 patients, and with medical journals publishing new COVID-19 research studies at breakneck speed, it can be difficult to keep up with the latest news and guidelines. Potential anti-coronavirus therapies can be divided into two categories depending on the target, one acting on the human immune system or human cells, and another, on the virus itself.
{"title":"Therapeutic and Preventive Approaches against COVID-19: A Review","authors":"Ilyes Zatla, L. Boublenza, H. Hassaine","doi":"10.37591/rrjomv.v11i3.2748","DOIUrl":"https://doi.org/10.37591/rrjomv.v11i3.2748","url":null,"abstract":"Several vaccines are found for the novel coronavirus SARS-CoV-2, responsible for the Coronavirus Disease 'COVID-19' but with a no clear, unified and effective treatment plan, nor definitive therapies for it, but only a variety of potential approaches. The objective of this work was to present, an overview of a variety of therapeutic and preventive approaches that have been applied instead, in a matter to calm the fatal viral pneumonia and developing safe, effective, anti-coronavirus therapeutic agents from naturally derived compounds would make a hopeful solution to end this pandemic. A number of experimental therapies have been rushed into clinical trials for COVID-19 patients, and with medical journals publishing new COVID-19 research studies at breakneck speed, it can be difficult to keep up with the latest news and guidelines. Potential anti-coronavirus therapies can be divided into two categories depending on the target, one acting on the human immune system or human cells, and another, on the virus itself.","PeriodicalId":230442,"journal":{"name":"Research & Reviews: A Journal of Microbiology and Virology","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132795831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：